SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-19-000273
Filing Date
2019-01-03
Accepted
2019-01-03 17:18:44
Documents
16

Document Format Files

Seq Description Document Type Size
1 425 form425.htm 425 84311
2 image1.jpg GRAPHIC 103909
3 image2.jpg GRAPHIC 394570
4 image3.jpg GRAPHIC 324135
5 image4.jpg GRAPHIC 451632
6 image5.jpg GRAPHIC 320007
7 image6.jpg GRAPHIC 521824
8 image7.jpg GRAPHIC 321867
9 image8.jpg GRAPHIC 555343
10 image9.jpg GRAPHIC 641878
11 image10.jpg GRAPHIC 387538
12 image11.jpg GRAPHIC 409019
13 image12.jpg GRAPHIC 329731
14 image13.jpg GRAPHIC 450013
15 image14.jpg GRAPHIC 455062
16 image15.jpg GRAPHIC 372305
  Complete submission text file 0001140361-19-000273.txt   8404018
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filed by) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Subject) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-34912 | Film No.: 19506963
SIC: 2834 Pharmaceutical Preparations